| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |